Back to Studies P1030 / Lopinavir/Ritonavir in HIV-1 Infected Infants A Phase I/II Study of Lopinavir/Ritonavir in HIV-1 Infected Infants <6 Months of Age OverviewSitesProtocol TeamPublications/Presentations Study Status Concluded DAIDS Number 10041 IND Number 64,585 Primary Protocol Team Members Ellen Chadwick Study Co-Chair Ram Yogev Study Vice-Chair Ellen Chadwick Study Co-Chair Jorge Pinto Study Co-Chair Marisa Mussi-Pinhata Investigator Loading study documents... Loading study sites... Loading study protocol team... Loading study press... Loading study publications/presentations...